← Back to Clinical Trials
Recruiting NCT06374433

NCT06374433 Investigating the Plasticity of Human Predictive Coding Through Neuromodulation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06374433
Status Recruiting
Phase
Sponsor Università Vita-Salute San Raffaele
Condition Human Brain and Cognition
Study Type INTERVENTIONAL
Enrollment 210 participants
Start Date 2024-06-13
Primary Completion 2026-04-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Occipital tACS at IAF-2HzOccipital tACS at IAF+2HzFrontal tACS at 4-7 Hz

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 210 participants in total. It began in 2024-06-13 with a primary completion date of 2026-04-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The hypothesis of the study is to investigate how different trm (tES) methods (transcranial Alternating Current Stimulation, tACS, and transcranial Random Noise Stimulation, tRNS) applied at different stimulation frequencies and networks can modulate the predictive mechanisms in human perception and cognition. This is an interventional, monocentric, cross-sectional randomized, single-blinded study on healthy adult volunteers, recruited through online advertisements, flyers and oral transmission. Volunteers will be recruited from the general population of young adults.

Eligibility Criteria

Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Aged 18-35 years. * Normal or corrected to normal vision, as per anamnestic investigation. Exclusion Criteria: * Participants with a diagnosis of epilepsy (as per anamnestic investigation). * Participants with major neurological disorders (as per anamnestic investigation). * Participants that are currently under psychopharmacological treatment with tricyclic antidepressants (as per anamnestic investigation). * Participants with metal implants in the brain, pacemakers, brain stimulators, cochlear implants (as per anamnestic investigation).

Contact & Investigator

Central Contact

Luca Ronconi, PhD

✉ ronconi.luca@unisr.it

📞 0226434887

Frequently Asked Questions

Who can join the NCT06374433 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Human Brain and Cognition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06374433 currently recruiting?

Yes, NCT06374433 is actively recruiting participants. Contact the research team at ronconi.luca@unisr.it for enrollment information.

Where is the NCT06374433 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT06374433 clinical trial?

NCT06374433 is sponsored by Università Vita-Salute San Raffaele. The trial plans to enroll 210 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology